 |
BR54599 |
2-Methyl-N-3-pyridinyl-2-propenamide |
40000-71-3 |
|
|
VIEW DETAILS > |
 |
BB50767 |
2-methyl-N-pyridin-4-ylacrylamide |
40000-72-4 |
C9H10N2O |
162.1885 |
VIEW DETAILS > |
 |
BR54559 |
N-(2-Chloro-3-pyridinyl)-2-methyl-2-propenamide |
40000-78-0 |
|
|
VIEW DETAILS > |
 |
AF60228 |
3,4-Dihydro-1h-[1,8]naphthyridin-2-one |
40000-79-1 |
C8H8N2O |
148.16191999999998 |
VIEW DETAILS > |
 |
BD12374 |
1,8-Naphthyridin-2(1H)-one, 3,4-dihydro-3-methyl- |
40000-80-4 |
C9H10N2O |
162.1885 |
VIEW DETAILS > |
 |
AF88151 |
3-Methyl-1,2-dihydro-1,8-naphthyridine-2-one |
40000-89-3 |
C9H8N2O |
160.1726 |
VIEW DETAILS > |
 |
BG42307 |
Adamantanyl-N-(3-bromophenyl)formamide |
400006-85-1 |
C17H20BrNO |
334.2508 |
VIEW DETAILS > |
 |
BL06113 |
4-[4,6-Bis(2,2,2-trifluoroethoxy)pyrimidin-2-yl)methylthio]aniline |
400007-74-1 |
|
|
VIEW DETAILS > |
 |
AZ00500 |
Benzene, 2-bromo-1,3-dimethoxy-5-(phenylmethoxy)- |
400008-16-4 |
C15H15BrO3 |
323.1818 |
VIEW DETAILS > |
 |
AF94039 |
Cantuzumab mertansine |
400010-39-1 |
|
|
VIEW DETAILS > |